Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)

Kimberly Wetherington (Creator)

Institution

East Carolina University (ECU )

Web Site: http://www.ecu.edu/lib/

Abstract: Hepatitis A (HAV) and B (HBV) are highly transmittable, vaccine-preventable infections that can cause chronic infection, increased risk for hepatocellular carcinoma, and cirrhosis. Individuals with chronic liver disease are at an increased risk for developing these complications if infected with either condition. Current national guidelines recommend HAV and HBV screening and vaccination for all individuals with chronic liver disease. Research shows that approximately half of the patients with chronic liver disease are not adequately screened for and vaccinated against HAV and HBV despite these recommendations. A quality improvement project utilizing the Plan Do Study Act (PDSA) cycle was performed in an outpatient gastroenterology clinic setting with the intent of increasing HAV and HBV screenings and vaccinations in patients with chronic liver disease. Components from the 4 Pillars Practice Transformation Program framework, which utilizes evidence-based research to improve vaccination uptake in outpatient settings, were also applied.

Additional Information

Publication

Other

Language: English

Date: 2023

Subjects

hepatitis A, hepatitis B, chronic liver disease, hepatitis A and hepatitis B vaccinations, hepatitis A and B screening, hepatitis A and B education, patient education, PDSA cycle, quality improvement, 4 Pillars Practice Transformation Program framework

Email this document to